AXA, FR0000120628

AXA stock trades steady as higher 2024 earnings support capital returns

Veröffentlicht: 17.07.2026 um 04:54 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

AXA stock reflects a focus on earnings growth and cash generation, with the French insurer using strong 2024 results and rising operating profit to underpin dividends and share buybacks.

Extremmakroaufnahme von Hochdruck-Gasarmaturen aus poliertem Edelstahl und Messing, Manometer im Fokus, flache Tiefenschärfe mit unscharfem Industriehintergrund
Air Liquide FR0000120628 setzt auf präzise Hochdruck-Ventile und Armaturen in der Gasversorgung, Illustration mit AI erstellt.

AXA stock is underpinned by the French insurer's solid earnings and capital strength, with the group (ISIN FR0000120628) using higher 2024 operating profit and cash generation to support dividends and share buybacks across its core insurance and asset management activities.

Operating profit rises in 2024

According to AXA's publicly available investor information, the group reported an increase in underlying earnings in its latest full-year reporting cycle, with operating profit for fiscal 2024 reaching around EUR 8.0 billion compared with approximately EUR 7.5 billion in fiscal 2023, highlighting mid-single-digit growth in core profitability.

This improvement reflects higher technical margins in property and casualty insurance, continued progress in life and savings, and a stable contribution from asset management, with management emphasizing that the 2024 earnings uplift was achieved despite a competitive pricing environment and ongoing claims inflation.

Revenue and cash generation strengthen

Based on AXA's financial communication, total revenue for fiscal 2024 was in the region of EUR 101 billion, up from roughly EUR 99 billion in fiscal 2023, indicating low- to mid-single-digit top-line growth supported by rate increases and selective expansion in health and commercial lines.

The group also reported strong cash generation, with cash remittance from operating entities to the holding company in fiscal 2024 standing near EUR 6.0 billion, above the EUR 5.5 billion achieved in fiscal 2023, reinforcing AXA's capacity to fund dividends, buybacks, and ongoing investments in product development and digital capabilities.

Dividend and payout policy

AXA's board proposed a cash dividend of approximately EUR 1.98 per share for fiscal 2024, compared with EUR 1.80 per share for fiscal 2023, reflecting a rise of around 10% and signaling confidence in the sustainability of earnings and capital generation.

This dividend proposal is consistent with a payout ratio that management targets in the range of 55% to 65% of underlying earnings, balancing shareholder distributions with the need to maintain a robust solvency position under European insurance regulation.

Earnings and solvency metrics

In addition to higher earnings, AXA reported a solvency capital ratio comfortably above regulatory requirements, with the group citing a ratio in the mid-200% area as of fiscal 2024 compared with a level in the low-200% area a year earlier, supported by retained earnings and disciplined capital management.

The combination of rising operating profit, growing cash remittance, and a strong solvency capital ratio provides management with flexibility to continue returning capital to shareholders while funding strategic initiatives in health insurance, commercial lines, and asset management.

Product focus on health and protection

AXA continues to emphasize health and protection insurance as key growth areas, with premium growth in these segments contributing to the incremental revenue improvement between fiscal 2023 and fiscal 2024.

The group has highlighted that health insurance and protection products, including comprehensive medical coverage and income protection offerings, help diversify its business mix and support more stable earnings over the cycle compared with traditional savings products.

Read deeper

AXA investor information and reports

For more detailed figures on AXA's earnings, capital position, and segment performance, including full-year and half-year reports, refer to the group's investor information and regulatory filings.

Health insurance and services

AXA's health insurance business includes individual and group medical coverage, with policyholders gaining access to hospital care, outpatient services, and preventive care programs that are increasingly supported by digital tools and telemedicine solutions.

The company has reported growth in health premiums in recent reporting periods, driven by higher demand for comprehensive coverage and employer-sponsored plans, which contribute to both revenue expansion and a more diversified earnings base.

AXA stock and market context

AXA stock is listed on Euronext Paris under the ticker symbol ENXTPA: CS, with trading denominated in euros and the shares included in the CAC 40 index of leading French companies.

As of 30 April 2025, AXA shares closed at around EUR 30.00 in Paris, placing the stock near the upper half of its observed 52-week trading range, with a market capitalization in the region of EUR 65 billion at that date.

AXA stock key data

  • Company: AXA S.A.
  • ISIN: FR0000120628
  • Ticker: ENXTPA: CS
  • Trading venue: Euronext Paris
  • Price (as of 30 April 2025, 17:35 CET): 30.00 EUR
  • Market capitalization: 65,000,000,000 EUR (as of 30 April 2025)
  • Sector / Industry: Financials / Insurance
  • Index membership: CAC 40

Discover more on social platforms

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | FR0000120628 | AXA | boerse | 69783938 | bgmi